Cabozantinib

Digestive System Neuroendocrine Tumor, Grade 1/2

Explore 6 assets in Digestive System Neuroendocrine Tumor, Grade 1/2 →

National Cancer Institute (NCI)Small moleculePhase 3

—

Rating in progress

Cabozantinib in Digestive System Neuroendocrine Tumor, Grade 1/2 is in the Floatz rating universe. The engine has not yet published a v0.2 rating for this asset. This page will update automatically once scoring completes.

Methodology v0.2 · Active